Bellicum Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.33 |
Market Cap |
$80.98 M |
Shares Outstanding |
46.01 M |
Public Float |
39.9 M |
Address |
Life Science Plaza Houston Texas 77030 United States |
Employees | - |
Website | http://www.bellicum.com |
Updated | 07/08/2019 |
Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. It uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. The company was founded by Kevin M. |